In the present study, we aimed to investigate whether post-injury pharmacological inhibition of the CCL2-CCR2 axis could mitigate inflammation and lung damage in a well-established rat model of acute lung injury (ALI). Here, CCR2 is linked to acute respiratory distress syndrome.